CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, Haydar, Altshuler, David, Cappellini, M. Domenica, Chen, Yi-Shan, Domm, Jennifer, Eustace, Brenda K., Foell, Juergen, de la Fuente, Josu, Grupp, Stephan, Handgretinger, Rupert, Ho, Tony W.
, Kattamis, Antonis, Kernytsky, Andrew, Lekstrom-Himes, Julie, Li, Amanda M., Locatelli, Franco, Mapara, Markus Y., de Montalembert, Mariane, Rondelli, Damiano, Sharma, Akshay
, Sheth, Sujit, Soni, Sandeep, Steinberg, Martin H., Wall, Donna, Yen, Angela and Corbacioglu, Selim
(2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
New England Journal of Medicine 384 (3), pp. 252-260.
Date of publication of this fulltext: 29 Feb 2024 12:27
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | New England Journal of Medicine | ||||
| Publisher: | MASSACHUSETTS MEDICAL SOC | ||||
|---|---|---|---|---|---|
| Place of Publication: | WALTHAM | ||||
| Volume: | 384 | ||||
| Number of Issue or Book Chapter: | 3 | ||||
| Page Range: | pp. 252-260 | ||||
| Date | 2021 | ||||
| Institutions | Medicine > Lehrstuhl für Kinder- und Jugendmedizin | ||||
| Identification Number |
| ||||
| Keywords | FETAL-HEMOGLOBIN; RISK-FACTORS; BCL11A; GENOME; TRANSPLANTATION; THERAPY; ASSOCIATION; MORBIDITY; ENHANCER; BLOOD; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 56388 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric